Vitamin Price Fixing Lawsuit
December 17, 2009
By: Johnny Justice
A $25.03 million lawsuit has been launched involving a vitamin price fixing conspiracy! The settlement is on behalf of consumers and businesses that purchased certain vitamins between 1988 and 2000 and reside in Nevada or 22 settling states. This settlement follows an earlier $225 million settlement reached in 2000 involving the same vitamins but different vitamin manufacturers.
The companies that sold these vitamins and subject to the $25.03 million settlement are:
December 17, 2009

A $25.03 million lawsuit has been launched involving a vitamin price fixing conspiracy! The settlement is on behalf of consumers and businesses that purchased certain vitamins between 1988 and 2000 and reside in Nevada or 22 settling states. This settlement follows an earlier $225 million settlement reached in 2000 involving the same vitamins but different vitamin manufacturers.
???Many competing vitamin manufacturers agreed to fix the prices of vitamins they sold, which artificially raised those vitamins??? prices,??? said Masto. ???This conduct will not be tolerated, especially when essential health products are involved. I am pleased to work with other states to help secure this settlement.???
The vitamins affected by this alleged price fixing conspiracy are: vitamin A, astaxanthin, vitamin B1 (thiamin), vitamin B2 (riboflavin), vitamin B3 (niacin), vitamin B4 (choline chloride), vitamin B5 (calpan), vitamin B6, vitamin B9 (folic acid), vitamin B12 (cyanocobalamine pharma), beta-carotene, vitamin C, canthaxanthin, vitamin E, and vitamin H (biotin), as well as all blends and forms of these vitamins. Also included is Premix, a product that contains one or more these vitamins in combination with other substances.
The companies that sold these vitamins and subject to the $25.03 million settlement are:
- Akzo Nobel Inc.
- Bioproducts Incorporated.
- Mitsui & Co., Ltd.
- Mitsui & Co. (U.S.A.), Inc.
- Chinook Global Limited and Chinook Group, Inc.
- Evonik Degussa GmbH, successor to Degussa AG.
- Evonik Degussa Corporation
- Lonza AG
- Merck KGaA, E. Merck and EM Industries, Inc.
- Nepera, Inc.
- Sumitomo Chemical America, Inc.
- Sumitomo Chemical Co., Ltd.
- Mitsubishi Tanabe Pharma Corporation and Tanabe U.S.A., Inc.
- UCB Pharma, Inc.
- Vertellus Specialties Inc. and Vertellus Chemicals SA.